Falls and fractures with atypical antipsychotic medication use: A population-based cohort study

JAMA Internal Medicine

Volumn 175, Issue 3, 2015, Pages 450-452

  Fraser, Lisa Ann ^a   Liu, Kuan ^b   Naylor, Kyla L ^a   Hwang, Y Joseph ^a,c   Dixon, Stephanie N ^b   Shariff, Salimah Z ^b   Garg, Amit X ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AGED; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG USE; FALLING; FEMALE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; LETTER; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VERY ELDERLY; FRACTURES, BONE;

ACCIDENTAL FALLS; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COHORT STUDIES; DIBENZOTHIAZEPINES; FEMALE; FRACTURES, BONE; HUMANS; MALE; RISPERIDONE;

EID: 84924055190     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.6930     Document Type: Letter

References (6)

1. Gellad WF, Aspinall SL, Handler S.M., et al. Use of antipsychotics among older residents in VA nursing homes. Med Care. 2012; 50(11):954-960.
2. Rigler SK, Shireman TI, Cook-Wiens GJ, et al. Fracture risk in nursing home residents initiating antipsychotic medications. J Am Geriatr Soc. 2013; 61(5): 715-722.
3. Oderda LH, Young JR, Asche C.V., Pepper GA. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann Pharmacother. 2012; 46(7-8): 917-928.
4. Pouwels S, van Staa TP, Egberts AC, Leufkens HG, Cooper C, de Vries F. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporos Int. 2009; 20(9):1499-1506.
5. Ma H, Huang Y, Cong Z., et al. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials [published online July 2, 2014]. J Alzheimers Dis. doi:10.3233/JAD-140579.
6. Hwang YJ, Dixon SN, Reiss J.P., et al. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med. 2014; 161(4):242-248.